Scilex Holding - Nilai Akuntansi saben Saham SCLX

Scilex Holding Company (SCLX) is a biopharmaceutical player developing non-opioid pain management solutions. Protected patents and consistent demand ensure high margins and a stable cash flow, which currently stands at -43.97. This price chart on GURU.Markets complements revenue data from the sale of innovative sprays and patches. The company's environmental policy focuses on proper waste disposal and the gradual reduction of its carbon footprint.

For Scilex Holding Company (SCLX), with its scalable distribution network for analgesic patches, the reported book value per share serves as an indicator of net asset capitalization. This metric is calculated as the difference between total assets and liabilities divided by the number of shares outstanding, allowing investors to determine the business's intrinsic value and assess the margin of safety during market corrections.